Back

Prognostic impact of RAASi and MRA Use in de novo HFrEF Patients with Renal Dysfunction and Hyperkalemia: Insights from the COEDO-AHF Registry"

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Novel therapies in heart failure: impact on outcomes Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Fumika Yoneyama

Saitama Medical Center, Kawagoe (Japan)

7 More presentations in this session

Presentation thumbnail
Clinical and echocardiographic long-term follow-up after transcoronary ablation of septal hypertrophy - a retrospective register analysis
Doctor F. Becker (Munich, DE)
Abstract Slides Video
Presentation thumbnail
High-dose guideline-directed medical therapy at discharge reduces mortality in hospitalized patients with heart failure with reduced ejection fraction: evidence from the HEROES study
Professor P. Krzesinski (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
The association between malnutrition and adverse outcome in patients with chronic heart failure who underwent cardiac resynchronization therapy
Doctor Y. Ono (Chiba, JP)
Abstract Slides Video
Presentation thumbnail
Both BNP and left ventricle diastolic diameter can predict all-cause mortality among Colombian asymptomatic, Trypanosoma cruzi-seropositive carriers after 22 years: results of the CHICAMOCHA cohort
Professor J. Villar (Bogota, CO)
Abstract Slides Video
Presentation thumbnail
Prevalence and outcomes of iron deficiency based on transferrin saturation in patients with acute heart failure
Doctor K. Tsuda (Takatsuki, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Novel therapies in heart failure: impact on outcomes

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Optimisation of renin-angiotensin-aldosterone system inhibitors use in chronic kidney disease patients with heart failure: is hyperkalaemia a barrier?
thumbnail
Congress Presentation
Renin-angiotensin-aldosterone system inhibitor discontinuation and its impact on one-year mortality in heart failure patients with acute kidney injury: a propensity matched analysis
thumbnail
Congress Presentation
Patiromer use for the treatment of hyperkaliemia in patients with heart failure and chronic kidney disease, real-world experience

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources